Nakul Pasricha Appointed as Additional Independent Director at Hindustan Construction Company Limited
Hindustan Construction Company Limited has appointed Mr. Nakul Pasricha as an Additional (Non-Executive Independent) Director. The appointment was made by the Board of Directors and is effective from July 10, 2026.The addition of Mr. Pasricha comes following recommendations by the Nomination and Remuneration Committee. He has been appointed for a term of five consecutive years, not liable to retire by rotation.
The appointment is conditional upon obtaining approval from the Members of the Company during the ensuing General Meeting or within three months of the appointment date, whichever occurs earlier.
Profile and Expertise
Mr. Nakul Pasricha is detailed as a versatile business leader possessing over 27 years of experience spanning various industries and company sizes across multiple geographies. He currently serves as the MD & CEO for PharmaSecure, an organization focused on technology-enabled anti-counterfeiting solutions serving the pharmaceutical sector in India, Africa, and globally.At PharmaSecure, Mr. Pasricha was instrumental in developing patented technology solutions designed to protect medicines and supply chains from counterfeiting. He led the company's growth, enabling it to serve over 100 companies in the pharmaceutical and related sectors, with more than 10 billion packs protected across India and Africa to date. Furthermore, he is a co-inventor of the technology engine that drives PharmaSecure’s authentication solution.
Industry Leadership
Mr. Pasricha maintains active involvement in industry advocacy concerning anti-counterfeiting solutions. He serves on the governing body of the Authentication Solution Providers' Association (ASPA), a not-for-profit body dedicated to research and awareness regarding counterfeiting prevention. Mr. Pasricha has been elected President of ASPA for two terms and currently holds the position of Vice President, advocating strongly against losses incurred by counterfeiting.His professional commitments also include serving as a Board Director for several entities, including PharmaSecure Inc. (USA), PharmaSecure PAS India Pvt. Ltd., Flexing It Services Pte Ltd. in Singapore, and Flexing It Services Pvt. Ltd.
Regarding the company’s internal structure, Mr. Nakul Pasricha is not related to any existing Director of Hindustan Construction Company Limited.
HCC Stock Price Movement
On Friday, shares of Hindustan Construction Company Limited gained momentum, settling at ₹23.89 after climbing 2.31%. The stock traded within a single-day range bounded by a low of ₹23.51 and a high of ₹24.33.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.